抄録
When we examine a patient with symptoms of acute enteritis in the course of chemotherapy with oral fluoropyrimidines such as uracil-tegafur (often referred to as UFT), we usually suspect 5-fluorouracil-induced enterocolitis. In case of persistent clinical symptoms despite discontinuation of chemotherapy, cytomegalovirus colitis should be considered in the differential diagnosis of chemotherapy-induced enterocolitis. We herein report the case of a patient who underwent surgery for lung adenocarcinoma followed by postoperative adjuvant chemotherapy with uracil-tegafur and was diagnosed as having cytomegalovirus colitis during the therapy. In the course of chemotherapy, cytomegalovirus colitis occasionally occurs even though the patient does not experience severe myelosuppression; thus, it is necessary that we recognize its potential occurrence.
本文言語 | English |
---|---|
ページ(範囲) | 826-829 |
ページ数 | 4 |
ジャーナル | Journal of Infection and Chemotherapy |
巻 | 22 |
号 | 12 |
DOI | |
出版ステータス | Published - 2016 12月 1 |
ASJC Scopus subject areas
- 微生物学(医療)
- 薬理学(医学)
- 感染症